Abstract
ABSTRACT This paper provides a review of the opportunities under current law (including recent developments) for a company to include health-related claims in labeling for products that will be subject to regulation only as “foods,” not as “drugs” (and that, therefore, will not be required to comply with “drug” approval requirements).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of Nutraceuticals, Functional & Medical Foods
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
